RightBio Metrics Introduces New FDA Cleared Point-of-Care Devices to Provide Safer, Cleaner and More Accurate Gastric pH Readings

RightBio Metrics introduces three new devices to provide safer, cleaner and more accurate gastric pH readings: RightSpot pH Indicator, RightSpot Infant pH Indicator and RightLevel pH Detector. (PRNewsFoto/RightBio Metrics)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";PHOENIX, June 11, 2014 /PRNewswire/ -- RightBio Metrics, an emerging leader in advanced fluid measurement technologies, today announces the availability of three new products after receiving both FDA and CE Mark approvals to distribute their point-of-care diagnostic devices. The approved devices, designed to provide safer nasogastric (NG) tube placement and accurate gastric acidity measurement using an innovative in vitro pH indicator include, RightSpot pH Indicator, RightSpot Infant pH Indicator and RightLevel pH Detector.

Housed under the brand RightpH, the technologies accurately measure bio fluids at the bedside to enhance the speed and quality of medical treatment. They are safer, cleaner and more accurate than pH paper test strips used today, giving clinicians additional confidence in NG tube placement, and treatment decisions, without incurring substantial costs to verify placement using X-rays or fumbling with messy manual paper tests.

The RightSpot pH Indicator and RightSpot Infant pH Indicator are small, non-invasive devices that are used to verify gastric acidity to avoid misplacement of NG feeding/suction tubes and percutaneous endoscopic gastrostomy (PEG) tubes. The third device, the RightLevel pH Detector, quickly measures stomach pH levels of critically ill patients to aid in proper medication dosage for treating gastric ulcers and bleeding. All three products have received CLIA Waived status, which means the FDA has classified them as simple laboratory examinations and procedures that have an insignificant risk of an erroneous result, which makes it easier for hospitals to perform onsite and maintain per CAP regulations.

"As an emergency room physician, I experienced firsthand the devastating effects of improper NG tube placement and uncertainty about treatment-critical metrics due to antiquated technology. Seeing patients put at unnecessary risk ignited my passion to make much needed fluid measurement technology improvements," said Paul Gilbert, MD, co-founder and president, RightBio Metrics.

Roughly 12.6 million NG tubes were placed in 2012 in the U.S. alone and studies show between two and four percent were misplaced. Misplaced tubes are typically misguided into the lungs causing significant morbidity and mortality and costing medical providers millions of dollars. In fact, from 2001 to 2011, medical providers in the Chicago area paid more than 10 million dollars to resolve lawsuits filed for injuries and deaths caused by misplaced NG feeding and suction tubes.

"Care providers are continuously looking for solutions that combine quality improvement with financial responsibility. RightpH devices help clinicians put science into decision-making and increase certainty about tube placement and treatment decisions without losing critical time," stated Gilbert. "RightpH indicators also help hospitals save important resources by lowering the risk of readmission and malpractice claims, which position themselves as leaders in patient safety and clinician practice conditions."

Gilbert added, "In medicine, quick decisions have to be made in treatment environments that often do not permit the use of expensive equipment. While pH measurement has become standard practice to ensure better treatment, RightpH offers the first safe and efficient technologies for easy pH measurement. We're excited to equip providers with these valuable tools to help eliminate any further NG tube misplacements or mistreatment."

About RightBio Metrics
RightBio Metrics is an emerging leader in advanced bio fluid measurement technologies. The company's RightpH line of products accurately measure bodily fluid metrics to enhance the speed and quality of medical treatment at the point-of-care and reduce healthcare costs associated with mistreatment and alternative verification methods. To learn more, please visit RightBioMetrics.com.

Photo - http://photos.prnewswire.com/prnh/20140610/116838

SOURCE RightBio Metrics

RELATED LINKS
http://www.rightbiometrics.com

reade more... Résuméabuiyad

Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors

COMMACK, N.Y., July 2, 2014 /PRNewswire/ -- It is a great honor for Avery Biomedical Devices, Inc. (ABD) to announce the appointment of the world-renowned Thoracic and Cardiovascular surgeon, Mark E Ginsburg, M.D., to its Board of Directors.

Dr. Ginsburg, with over 34 years of experience, is currently practicing at two facilities: NY Presbyterian Hospital and Good Samaritan Regional Medical Center. Dr. Ginsburg has been implanting the Avery Breathing Pacemaker since the late 1980's and is considered an expert in the implantation of the Avery System. In addition, he has travelled the world to implant the Avery System in those patients who are unable to travel to the United States. He has published numerous scientific papers and books such as Lung Volume Reduction Surgery (LVRS) and Emphysema Treatments. In addition, he was lead investigator on several clinical trials.

Martin Dobelle, CEO, states, "We are humbled to have Dr. Ginsburg join our Board of Directors. His experience and expertise will be invaluable to the future growth of ABD."

Dr. Ginsburg states, "It is a privilege to serve on the Board of Directors of ABD. This company has served the world's need in diaphragm pacing. Exciting new products are under development in this and related arenas as well. I look forward to providing medical and surgical input to the Board."

ABOUT ABD

Avery Biomedical Devices, Inc. is a privately-held company located on Long Island, New York. It manufactures the Avery Breathing Pacemaker System: an implanted diaphragmatic pacemaker which is used to free many quadriplegics, central sleep apnea and diaphragm paralysis patients from mechanical ventilation. Most patients strongly prefer pacing to mechanical ventilation for reasons such as breathing and speech patterns, ease of eating and drinking and improved sense of smell. Since breathing pacemakers costs far less than mechanical ventilation and do not use percutaneous wire that pass through the skin (infection risk), it is the more prudent choice for life support.

The Avery Breathing Pacemaker is the only device of its kind with premarket approval from the USFDA and CE marking privileges under the European Active Implantable Medical Device Directive. Should you know of a patient with quadriplegia, central sleep apnea, diaphragm paralysis or another condition that may benefit from an Avery Breathing Pacemaker, please contact us.

CONTACT:
Martin D. Dobelle, CEO
631-864-1600
www.averybiomedical.com

SOURCE Avery Biomedical Devices, Inc.

RELATED LINKS
http://www.averybiomedical.com/

reade more... Résuméabuiyad

NexID First To Offer "Liveness Detection" Software For Mobile Devices

WASHINGTON, March 18, 2014 /PRNewswire/ -- As mobile device manufacturers embed fingerprint ID into millions of smartphones, NexID Biometrics today introduces its Mobile Live Finger Detection (LFD) software, the first liveness detection solution designed specifically to exceed the convenience and security needs of mobile users worldwide.  The software provides authentication rates as high as 94-97 percent, offering the highest levels of "spoof-proofing" software available on the market today.   

NexID developed the Mobile LFD software solution specifically for mobile devices.  Due to the variety of fingerprint-scanning solutions on the market, the company designed the software to be technology agnostic so it could work with all fingerprint sensors and mobile devices, while achieving fast execution times and resource efficiency.

The Mobile LFD software resides in a mobile device and detects whether an image captured by the device's fingerprint sensor is detecting a finger from a living person or if it's a fake or "spoofed" fingerprint. 

Adding live finger detection enhances the device's security and helps eliminate unlocking a phone or one of its applications that may contain confidential information.  As evidenced with Apple's iPhone 5S TouchID, fingerprint sensors are actually highly vulnerable to hacking without some form of liveness detection.

NexID will introduce Mobile LFD here this week in Booth #202 at the Connect: ID Expo, where company executives will discuss and illustrate fingerprint spoofing techniques and fake finger detection.  Additionally, Clarkson University professor and NexID co-owner, Dr. Stephanie Schuckers, will be speaking at the conference at 1:50 p.m. today on the topic of "Fake Fingers and Stolen Templates: Topics in Biometric Security."

"Two of the world's leading mobile device makers now include fingerprint identification on their devices, so it doesn't take a crystal ball to see that trend continuing," said NexID COO Mark Cornett.  "We believe every mobile device will incorporate some type of fingerprint ID functionality in the next couple of years. And with people relying more and more on their devices, the security of personal, financial, health and business information is not just needed, it's imperative. "  

For example, businesses contemplating adopting Bring Your Own Device (BYOD) programs face the need to ensure company information on mobile devices remains private and secure; meanwhile, employees may opt for more convenience to access phone features on the same devices.  Mobile LFD offers a sliding scale of security for fingerprint ID on smartphones, allowing for a simple and flexible solution. 

NexID said its Mobile LFD can immediately enhance the myriad of fingerprint ID solutions being developed by sensor manufacturers, mobile devices companies, and application developers.  Fingerprint sensor companies can embed the software directly onto a sensor's chip (LFD on chip), and device manufacturers can add it to the main processor (LFD on host), all to provide customers with a convenient alternative to traditional PINs and passwords. NexID's Mobile LFD solution can also be embedded in "trust zone" or trusted execution environment chip sets.

The Mobile LFD SDK will be distributed free for evaluation, solution integration, and testing purposes.  NexID also offers professional services to assist with the solution integration process.  Licensing and distribution agreements are negotiated separately.

For more information on NexID Mobile LFD, please visit www.nexidbiometrics.com.  A white paper on liveness detection, including examples of how the company researches and tests different "spoofing" techniques, is also available.

About NexID Biometrics
NexID Biometrics is a leading software and technology supplier to the biometric authentication industry. The company develops and licenses liveness detection software that enables fingerprint-scanning technologies to more accurately, and with greater confidence, authenticate scanned images by mitigating spoof-related risks. The company also provides testing and analysis of fingerprint scanning devices to identify existing vulnerabilities to known spoofing strategies. The company's founders represent some of the world's leading authorities on biometric spoof mitigation and liveness detection.

Logo - http://photos.prnewswire.com/prnh/20131016/SF97206LOGO

SOURCE NexID Biometrics

reade more... Résuméabuiyad

Global Market for Wearable Computing Devices Projected To Reach $30.2 Billion in 2018; Consumer Market Expected To Surge With 52% CAGR

WELLESLEY, Massachusetts, February 25, 2014 /PRNewswire/ --

BCC Research (http://www.bccresearch.com) reveals in its new report, Wearable Computing: Technologies, Applications, and Global Markets, the global market for wearable computing devices is expected to grow to $30.2 billion by 2018, with a five-year compound annual growth rate (CAGR) of 43.4%. The consumer market, the fastest moving segment overall, is projected to grow at a tremendous 52% CAGR.

Wearable or body-borne computers enable hands-free mobile real-time data monitoring, logic calculation, and network communication. Consumer applications, including wearable cameras, activity trackers, smart clothing, smart glasses, smart watches, augmented reality and gaming devices, are expected to explode onto the market over the next few years, reaching $22.1 billion by 2018. Non-consumer markets (healthcare, defense/security, enterprise, and industrial) are expected to reach $8.1 billion by 2018.

The smart watch product category is projected to account for the largest single consumer market, generating more than $12.5 billion in global annual revenues in 2018.

"Key for the future widespread adoption of smart watches in consumer markets will be for products to leverage the single unique advantage of smart watches over smart phones," said BCC Research information technology analyst Adam Weigold. "In other words, products must target consumer applications where it is a distinct advantage for a smart device to be permanently worn to prevent it from being misplaced, lost, or stolen. Hence, applications such as remote location of personal items, home automation and mobile payment processing could be "killer apps" for the smart watch."

Wearable computing: technologies, applications and global markets provides an overview of the wearable computing devices market. The report discusses recent technological advances in materials sciences, electronics, photonics, and software that are enabling a potentially vast range of new lightweight, wearable computing products to emerge. The history and current state of the market is reviewed and the types of devices available are discussed. An analysis of the industry structure, including major companies and market shares, and major markets and market drivers is made. Likely future industry developments are discussed and the future evolution of the technology is predicted. Patent evaluation, including coverage of the current state of technology, new patent applications, and newly issued patents is also included. This report is intended for developers, manufacturers, providers, suppliers, users, customers, commentators, analysts, and investors interested in where the Wearable computing devices and accessories market is heading.

Editors and reporters, who wish to speak with the analyst, should contact Steven Cumming at steven.cumming@bccresearch.com.

About BCC Research

BCC Research publishes market research reports that make organizations worldwide more profitable with intelligence that drives smart business decisions. These reports cover today's major industrial and technology sectors, including emerging markets. For more than 40 years we've helped customers identify new market opportunities with accurate and reliable data and insight. These include, but are not limited to, market sizing, forecasting, industry overviews, and identification of significant trends and key competitors. We partner with analysts who are experts in specific areas of industry and technology. Their up-to-date knowledge gives our customers unbiased measurements and assessments of these vital markets. Because our reports offer a global focus, our customers include the top companies in industries around the world as well as universities, major business schools, start-ups, consulting firms and investment companies. BCC Research is a unit of Eli Research LLC.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49-2 Walnut Park, Wellesley, MA 02481, Telephone: (+1) 781-489-7301; Email: editor@bccresearch.com as the source and publisher. Thank you.

Contact: Steven Cumming
Additional Releases: http://www.bccresearch.com/pressroom

Tel: +1-978-870-3345
Fax: +1-781-489-7308
Email: steven.cumming@bccresearch.com

SOURCE BCC Research LLC

reade more... Résuméabuiyad